Analysis

Anixa Biosciences is intensifying its strategic focus on a pair of clinical-stage oncology assets. In a recent update, the company’s...

A significant Bitcoin acquisition and renewed Wall Street confidence have combined to reinvigorate interest in the shares of Strategy, the...

Investor attention is increasingly turning to Devon Energy, propelled by robust operational execution and forward-looking strategic initiatives. The U.S. energy...

Despite facing notable share price pressure since the start of the year, Danaher's management is projecting confidence through a significant...

The stability of Kinder Morgan's core business model is receiving renewed validation from U.S. regulators. As the Federal Energy Regulatory...

Hydrogenetics presents a unique investment case defined by its deliberate diversification across seemingly unrelated industries. While alternative energy forms a...

Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for...

In response to significant portfolio depreciation, Oxford Lane Capital has announced a strategic move to stabilize its financial position. The...

A significant rating change from JP Morgan has sent MercadoLibre's stock lower, casting a spotlight on the challenges facing the...

While Coinbase accelerates its expansion across Europe with new derivative offerings, several major financial institutions have expressed reservations about the...